Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_04382 |
| Species: | Homo sapiens |
| Position : | chr11:5301862-5302715 |
| Year: | 2004 |
| Title: | An insulator blocks spreading of histone acetylation and interferes with RNA polymerase II transfer between an enhancer and gene. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| PMID: | 15371553 |
| Tissue: | blood |
| Tissue Ontology ID: | UBERON:0000178 |
| Cell Source: | K-562 |
| CVCL ID: | CVCL_0004 |
| Cell Type: | malignant cell |
| Cell Ontology ID: | CL:0001064 |
| Experiment Type: | Enhancer-blocking assay; chromatin modification assay; functional perturbation assay |
| Low Throughput Method: | cHS4 insulator insertion; CTCF-site deletion; ChIP-qPCR for CBP/P300/RNA polymerase II/histone acetylation; DNase I hypersensitivity assay; restriction enzyme accessibility assay; RNase protection assay |
| Target gene : | HBE1 |
| TF name : | NA |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_02356 | chr11:5222500-5323700 | blood | erythroid cell | NA |
| E_02363 | chr11:5222500-5323700 | blood | erythroid cell | NA |
| E_02364 | chr11:5222500-5323700 | blood | erythroid cell | NA |
| E_02365 | chr11:5222500-5323700 | blood | erythroid cell | NA |
| E_03631 | chr11:5301485-5302895 | blood | malignant cell | NA |
| E_03230 | chr11:5301600-5302400 | blood / hematopoietic system | NA | NA |
| E_03231 | chr11:5301600-5302400 | blood / hematopoietic system | NA | NA |
| E_03232 | chr11:5301600-5302400 | blood / hematopoietic system | NA | NA |
| E_03070 | chr11:5301801-5302175 | pleural effusion | erythroid lineage cell | NA |
| E_03071 | chr11:5301801-5302175 | pleural effusion | erythroid lineage cell | NA |
| E_03200 | chr11:5301862-5302715 | blood | malignant cell | NA |
| E_03201 | chr11:5301862-5302715 | blood | malignant cell | NA |
| E_03202 | chr11:5301862-5302715 | blood | malignant cell | NA |
| E_03203 | chr11:5301862-5302715 | blood | malignant cell | NA |
| E_03204 | chr11:5301862-5302715 | blood | malignant cell | NA |
| E_03205 | chr11:5301862-5302715 | blood | malignant cell | NA |
| E_03206 | chr11:5301862-5302715 | blood | malignant cell | NA |
| E_03207 | chr11:5301862-5302715 | blood | malignant cell | NA |
| E_03210 | chr11:5301862-5302715 | blood | erythroid-like cell | NA |
| E_03211 | chr11:5301862-5302715 | blood | erythroid-like cell | NA |
| E_03212 | chr11:5301862-5302715 | blood | erythroid-like cell | NA |
| E_03213 | chr11:5301862-5302715 | blood | erythroid-like cell | NA |
| E_04277 | chr11:5301862-5302715 | blood | malignant cell | NA |
| E_04567 | chr11:5301862-5302715 | blood | myeloid cell | NA |
| E_04237 | chr11:5301983-5302001 | pleural effusion | erythroid lineage cell | NA |
| E_04238 | chr11:5301983-5302001 | pleural effusion | erythroid lineage cell | NA |
| E_04245 | chr11:5301983-5302001 | uterine cervix | epithelial cell | NA |
| E_04246 | chr11:5301983-5302001 | uterine cervix | epithelial cell | NA |